[1. Fennerty MB. Helicobacter pylori. Arch Intern Med. 1994; 254:721-7.10.1001/archinte.1994.00420070021003]Search in Google Scholar
[2. Marshall B. Helicobacter pylori. Am J Gastroenterol. 1994; 89:S116-28.]Search in Google Scholar
[3. Colin WH, Richard HH. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol. 1998; 93:2330-8.10.1016/S0002-9270(98)00565-6]Search in Google Scholar
[4. Atherton JC. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997; 11 (Suppl 1):11-20.10.1046/j.1365-2036.11.s1.3.x]Search in Google Scholar
[5. CAM Stedman, ML Barclay. Review article: comparison of the pharmacokinetics. Acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000; 14:963-78.10.1046/j.1365-2036.2000.00788.x]Search in Google Scholar
[6. John H. The proton pump inhibitors: similarities and differences. Clinical Therapeutics. 2000; 22:266-79.10.1016/S0149-2918(00)80032-6]Open DOISearch in Google Scholar
[7. Chey WD, Spybrook M, Carpenter S, Nostrant TT, Elta GH, Scheiman JM. Prolonged effect of omeprazole on the 14C-urea breath test. Am J Gastroenterol. 1996; 91:89-92.]Search in Google Scholar
[8. Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther. 1999; 13:1287-93.10.1046/j.1365-2036.1999.00601.x10540042]Search in Google Scholar
[9. Savirino V, Bisso G, Pivari M, Zentilin P, Bilardi C, Dulbecco P, et al. Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine and omeprazole. Aliment Pharmacol Ther. 2000; 14:291-7.10.1046/j.1365-2036.2000.00721.x10735921]Search in Google Scholar
[10. Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A et al. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the 13C-urea breath test. Aliment Pharmacol Ther. 2002; 16:553-7.10.1046/j.1365-2036.2002.01192.x11876710]Search in Google Scholar
[11. Shirin H, Frenkel D, Shevah O, Levine A, Bruck R, Moss S, et al. Effect of proton pump inhibitors on the continuous real time 13C-urea breath test. Am J Gastroenterol. 2003; 98:46-50.10.1111/j.1572-0241.2003.07187.x12526935]Open DOISearch in Google Scholar
[12. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenteol. 2003; 98:1005-9.10.1111/j.1572-0241.2003.07426.x12809820]Search in Google Scholar
[13. Graham DY. An alternative explanation of the effect of citric acid on proton pump inhibitors-associated false negative urea breath tests. Am J Gastroenterol. 2001; 96:3032-9.10.1111/j.1572-0241.2001.04691.x]Search in Google Scholar
[14. Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY. et al. Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol. 1996; 91: 690-4. ]Search in Google Scholar
[15. Desroches JJ, Lahaie RG, Picard M, Morais J, Dumont A, Gaudreau C, et al. Methodological validation and clinical usefulness of carbon-14 urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med. 1997; 38: 1141-5.]Search in Google Scholar
[16. Katelaris PH, Jone B. Testing for Helicobacter pylori infection after antibiotic treatment. Am J Gastroenterol. 1997; 92:1245-7.]Search in Google Scholar
[17. Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, et al. Masking of 13C-urea breath test by proton pump inhibitors is dependent on type of medication: compare between omeprazole, pantoprazole, lansoprazole and esomeprazole. Aliment Pharmacol Ther. 2004; 20:117-22.10.1111/j.1365-2036.2004.02021.x15225178]Search in Google Scholar
[18. Stack WA, Kniffon A, Thirlwell D, Cockayme A, Jenkins D, Hawkey CJ, et al. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Am J Gastroenterol. 1998; 93:1909-13.10.1111/j.1572-0241.1998.00582.x9772054]Search in Google Scholar
[19. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanism of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sc. 1998; 43 (9 suppl):S5-13.]Search in Google Scholar
[20. Sakurai K, Osaka T, Yamasaki K. Rebamipide induces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Dig Dis Sc. 2005; 50 (Suppl 1):S90-6.10.1007/s10620-005-2812-516184427]Search in Google Scholar
[21. Arakawa T, Higuchi K, Fujiwara Y, Watanabe T, Tominaga K, Sasaki E, et al. 15th anniversary of rebamipide: looking ahead to new mechanism and new applications. Dig Dis Sc. 2005; 50 (Suppl 1):S3-11.10.1007/s10620-005-2800-916184418]Search in Google Scholar
[22. Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, et al. Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol. 2003; 38:937-41.10.1007/s00535-003-1176-x14614600]Open DOISearch in Google Scholar
[23. Adachi K, Fujishiro H, Mihara T, komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol. 2003; 18:168-71. 10.1046/j.1440-1746.2003.02922.x12542601]Search in Google Scholar
[24. Hayashi S, Sugiyama T, Amano K, Isogai E, Aihara M, Kikuchi M, et al. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob Agents Chemther. 1998; 42:1895-9.10.1128/AAC.42.8.18951057069687380]Search in Google Scholar